Evidence map›Paper›PMID 32923341›Full record

ArticleGlobal heart2020

Prevalence, Awareness, Treatment and Control of Hypertension in Nigeria: Data from a Nationwide Survey 2017.

Augustine N Odili, Babangida S Chori, Benjamin Danladi, Peter C Nwakile, Innocent C Okoye, Umar Abdullahi, Maxwell N Nwegbu, Kefas Zawaya, Ime Essien, Kabiru Sada and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Global heart, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 3 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 3 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Global trends in hypertension prevalence, awareness, treatment, and control.Current opinion in nephrology and hypertension · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

Augustine N OdiliCirculatory Health Research Laboratory, College of Health Sciences, University of Abuja, Abuja, NG.
Babangida S ChoriCirculatory Health Research Laboratory, College of Health Sciences, University of Abuja, Abuja, NG.
Benjamin DanladiCirculatory Health Research Laboratory, College of Health Sciences, University of Abuja, Abuja, NG.
Peter C NwakileDepartment of Community Health, University of Uyo Teaching Hospital, Uyo, Akwa Ibom, NG.
Innocent C OkoyeChukwuemeka Odumegwu Ojukwu University, Awka, Anambra, NG.
Umar AbdullahiDepartment of Medicine, Federal Medical Centre, Gusau, Zamfara, NG.
Maxwell N NwegbuCirculatory Health Research Laboratory, College of Health Sciences, University of Abuja, Abuja, NG.
Kefas ZawayaDepartment of Medicine, Federal Teaching Hospital Gombe, Gombe, NG.
Ime EssienDepartment of Medicine, University of Uyo, Akwa Ibom, NG.
Kabiru SadaDepartment of Medicine, Federal Medical Centre, Gusau, Zamfara, NG.
John O OgedengbeCirculatory Health Research Laboratory, College of Health Sciences, University of Abuja, Abuja, NG.
Akinyemi AjeDepartment of Medicine, University College Hospital, Ibadan, Oyo, NG.
Godsent C IsiguzoDepartment of Medicine, Federal Teaching Hospital, Abakaliki, Ebonyi, NG.
University of Abuja · NGFederal Medical Centre · NGChukwuemeka Odumegwu Ojukwu University · NGFederal Teaching Hospital Abakaliki · NGGombe State University · NGUniversity College Hospital, Ibadan · NGUniversity of Uyo · NGUniversity of Uyo Teaching Hospital · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous studies that evaluated the prevalence, awareness and treatment of hypertension in Nigeria were either localized to some specific regions of the country or non-standardized thereby making evaluation of trend in hypertension care difficult. Methods: We used the World Health Organization (WHO) STEPwise approach to chronic disease risk factor surveillance to evaluate in a nationally representative sample of 4192 adult Nigerians selected from a rural and an urban community in one state in each of the six geo-political zones of the country. Results: The overall age-standardized prevalence of hypertension was 38.1% and this varied across the geo-political zones as follows: North-Central, 20.9%; North-East, 27.5%; North-West, 26.8%; South-East, 52.8%; South-South, 44.6%; and South-West, 42.1%. Prevalence rate did not differ significantly (p > 0.05) according to place of residence; 39.2% versus 37.5 %; urban vs rural. Prevalence of hypertension increased from 6.8% among subjects less than 30 years to 63.0% among those aged 70 years and above. Awareness was better (62.2% vs. 56.6%; P = 0.0272); treatment rate significantly higher (40.9 % vs. 30.8%; P < 0.0001) and control similar (14 vs. 10.8%) among urban compared to rural residents. Women were more aware of (63.3% vs. 52.8%; P < 0.0001); had similar (P > 0.05) treatment (36.7 vs. 34.3%) and control (33.9% vs. 35.5%) rates of hypertension compared to men. Conclusion: Our results suggest a large burden of hypertension in Nigeria and a closing up of the rural-urban gap previously reported. This calls for a change in public health policies anchored on a primary health care system to address the emerging disease burden occasioned by hypertension.

Indexed as

AwarenessDisease ManagementRural PopulationAdultBlood PressureFemaleHumansHypertensionMaleMiddle AgedNigeriaPopulation SurveillancePrevalenceRisk FactorsAfricaAwarenessBlood pressureControlHypertensionPrevalenceTreatment

Identifiers

PMID32923341
PMCPMC7427662
OpenAlexW3042002122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.